CONMED Corp SEC filings CNMD

CONMED Corp has 1,000 filings in SEC EDGAR's recent list, going back to Mar 11, 2015. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.

CONMED Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 28, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
3 Initial insider ownership Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
3 Initial insider ownership Jul 2, 2026 Jul 1, 2026
3 Initial insider ownership Jul 2, 2026 Jul 1, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 17, 2026 Jun 17, 2026
11-K Employee savings plan report Jun 16, 2026 Dec 31, 2025
8-K Current report
Material agreement
Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
3/A Primary document Jun 3, 2026 Jun 1, 2026
3 Initial insider ownership Jun 3, 2026 Jun 1, 2026
8-K Current report
Material agreement, New debt
Jun 1, 2026 May 27, 2026
SD Specialized disclosure (conflict minerals) May 28, 2026 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 20, 2026 May 18, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
ARS Annual report to shareholders Apr 7, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 7, 2026 —
DEF 14A Proxy statement Apr 7, 2026 May 18, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4/A Primary document Mar 18, 2026 Mar 2, 2026
4/A Primary document Mar 18, 2026 Mar 2, 2026
4/A Primary document Mar 18, 2026 Mar 2, 2026
4/A Primary document Mar 18, 2026 Mar 2, 2026
4/A Primary document Mar 18, 2026 Mar 2, 2026
8-K Current report
Officer or director change
Mar 13, 2026 Mar 13, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
10-K Annual report Feb 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Jan 28, 2026 Jan 28, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Officer or director change
Jan 8, 2026 Jan 6, 2026
5 Annual insider ownership Jan 8, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Dec 5, 2025 Dec 5, 2025
4 Insider transaction Nov 24, 2025 Nov 21, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 21, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
4 Insider transaction Nov 7, 2025 Nov 6, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
144 Notice of proposed sale Nov 6, 2025 —
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
4 Insider transaction Nov 5, 2025 Nov 4, 2025
4 Insider transaction Nov 3, 2025 Oct 31, 2025
4 Insider transaction Sep 15, 2025 Sep 12, 2025
144 Notice of proposed sale Sep 12, 2025 —
4 Insider transaction Sep 9, 2025 Sep 8, 2025
8-K Current report
Officer or director change
Sep 9, 2025 Sep 8, 2025
3 Initial insider ownership Sep 9, 2025 Sep 8, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 8, 2025 Aug 7, 2025
8-K Current report
Other events
Aug 8, 2025 Aug 7, 2025
144 Notice of proposed sale Aug 7, 2025 —
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 18, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 7, 2025 Jul 7, 2025
11-K Employee savings plan report Jun 18, 2025 Dec 31, 2024
8-K Current report
Material agreement, New debt
Jun 16, 2025 Jun 10, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction May 30, 2025 May 29, 2025
SD Specialized disclosure (conflict minerals) May 29, 2025 —
4 Insider transaction May 21, 2025 May 20, 2025
8-K Current report
Officer or director change, Shareholder vote results, Other events
May 21, 2025 May 19, 2025
S-8 POS Filing May 20, 2025 —
S-8 POS Filing May 20, 2025 —
S-8 Employee stock plan registration May 20, 2025 —
4 Insider transaction May 15, 2025 Mar 3, 2025
3 Initial insider ownership May 15, 2025 Feb 24, 2025
DEFA14A Additional proxy material May 6, 2025 —
4 Insider transaction May 6, 2025 May 5, 2025
144 Notice of proposed sale May 5, 2025 —
3 Initial insider ownership May 1, 2025 Apr 28, 2025
4 Insider transaction May 1, 2025 Apr 28, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
4 Insider transaction Apr 8, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 May 20, 2025
5 Annual insider ownership Apr 7, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Apr 1, 2025 Apr 1, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
3 Initial insider ownership Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
8-K Current report
Officer or director change, Other events
Feb 25, 2025 Feb 24, 2025
10-K Annual report Feb 18, 2025 Dec 31, 2024
144 Notice of proposed sale Feb 14, 2025 —
4 Insider transaction Feb 13, 2025 Feb 11, 2025
144 Notice of proposed sale Feb 13, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
8-K Current report
Results of operations
Feb 5, 2025 Feb 5, 2025
3 Initial insider ownership Jan 31, 2025 Jan 27, 2025
4 Insider transaction Jan 30, 2025 Jan 27, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
8-K Current report
Other events
Dec 10, 2024 Dec 9, 2024
4 Insider transaction Nov 21, 2024 Nov 20, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
4 Insider transaction Nov 8, 2024 Nov 7, 2024
144 Notice of proposed sale Nov 8, 2024 —
4 Insider transaction Nov 6, 2024 Nov 4, 2024
3 Initial insider ownership Nov 6, 2024 Nov 4, 2024
4 Insider transaction Nov 5, 2024 Nov 1, 2024
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Results of operations, Officer or director change
Oct 30, 2024 Oct 30, 2024
8-K Current report
Results of operations
Oct 4, 2024 Oct 4, 2024
8-K Current report
Regulation FD disclosure
Sep 30, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Sep 20, 2024 Sep 16, 2024
4 Insider transaction Sep 9, 2024 Sep 5, 2024
144 Notice of proposed sale Aug 27, 2024 —
8-K Current report
Officer or director change
Aug 14, 2024 Aug 14, 2024
8-K Current report
Other events
Aug 9, 2024 Aug 9, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
3 Initial insider ownership Jul 1, 2024 Jul 1, 2024
11-K Employee savings plan report Jun 18, 2024 Dec 31, 2023
4 Insider transaction Jun 17, 2024 Jun 14, 2024
144 Notice of proposed sale Jun 14, 2024 —
4 Insider transaction Jun 5, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
3 Initial insider ownership Jun 3, 2024 Jun 3, 2024
8-K Current report
Officer or director change
May 28, 2024 May 22, 2024
8-K Current report
Shareholder vote results, Other events
May 22, 2024 May 22, 2024
SD Specialized disclosure (conflict minerals) May 21, 2024 —
4 Insider transaction May 14, 2024 May 13, 2024
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction Apr 26, 2024 Apr 24, 2024
10-Q Quarterly report Apr 25, 2024 Mar 31, 2024
8-K Current report
Officer or director change
Apr 24, 2024 Apr 19, 2024
8-K Current report
Results of operations
Apr 24, 2024 Apr 24, 2024
ARS Annual report to shareholders Apr 8, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 8, 2024 —
DEF 14A Proxy statement Apr 8, 2024 May 22, 2024
4 Insider transaction Apr 3, 2024 Mar 28, 2024
4 Insider transaction Apr 3, 2024 Mar 28, 2024
4 Insider transaction Mar 11, 2024 Mar 8, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Other events
Feb 27, 2024 Feb 26, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
CNMD (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Largo, FL
SEC filer status
Large accelerated filer
SEC CIK
816956

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.